Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58102650 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.58102650 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23010223 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.23010223 |
5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.14188648 |
6 | epoxygenase P450 pathway (GO:0019373) | 6.86812623 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 6.57444527 |
8 | omega-hydroxylase P450 pathway (GO:0097267) | 6.31102377 |
9 | high-density lipoprotein particle remodeling (GO:0034375) | 6.21671624 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.92899671 |
11 | negative regulation of fibrinolysis (GO:0051918) | 5.62445577 |
12 | kynurenine metabolic process (GO:0070189) | 5.61703955 |
13 | tryptophan catabolic process (GO:0006569) | 5.61694176 |
14 | indole-containing compound catabolic process (GO:0042436) | 5.61694176 |
15 | indolalkylamine catabolic process (GO:0046218) | 5.61694176 |
16 | regulation of cholesterol esterification (GO:0010872) | 5.60455674 |
17 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 5.45647645 |
18 | bile acid biosynthetic process (GO:0006699) | 5.44878938 |
19 | urea cycle (GO:0000050) | 5.44311222 |
20 | urea metabolic process (GO:0019627) | 5.44311222 |
21 | glyoxylate metabolic process (GO:0046487) | 5.44174128 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42134914 |
23 | protein carboxylation (GO:0018214) | 5.42134914 |
24 | androgen biosynthetic process (GO:0006702) | 5.40717479 |
25 | reverse cholesterol transport (GO:0043691) | 5.35518323 |
26 | tryptophan metabolic process (GO:0006568) | 5.34941487 |
27 | regulation of fibrinolysis (GO:0051917) | 5.33014779 |
28 | sulfur amino acid catabolic process (GO:0000098) | 5.29722637 |
29 | cysteine metabolic process (GO:0006534) | 5.25917716 |
30 | serine family amino acid catabolic process (GO:0009071) | 5.24796957 |
31 | protein-lipid complex remodeling (GO:0034368) | 5.22302157 |
32 | macromolecular complex remodeling (GO:0034367) | 5.22302157 |
33 | plasma lipoprotein particle remodeling (GO:0034369) | 5.22302157 |
34 | oxidative demethylation (GO:0070989) | 5.18519746 |
35 | negative regulation of sterol transport (GO:0032372) | 5.15798839 |
36 | negative regulation of cholesterol transport (GO:0032375) | 5.15798839 |
37 | phospholipid efflux (GO:0033700) | 5.10612109 |
38 | cellular ketone body metabolic process (GO:0046950) | 5.00954654 |
39 | nitrogen cycle metabolic process (GO:0071941) | 5.00034702 |
40 | tyrosine metabolic process (GO:0006570) | 4.90093451 |
41 | progesterone metabolic process (GO:0042448) | 4.89780867 |
42 | intestinal cholesterol absorption (GO:0030299) | 4.87387927 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 4.83579916 |
44 | plasma lipoprotein particle clearance (GO:0034381) | 4.81599962 |
45 | aromatic amino acid family metabolic process (GO:0009072) | 4.78276938 |
46 | drug catabolic process (GO:0042737) | 4.77165246 |
47 | triglyceride homeostasis (GO:0070328) | 4.74756659 |
48 | acylglycerol homeostasis (GO:0055090) | 4.74756659 |
49 | amino-acid betaine metabolic process (GO:0006577) | 4.72635958 |
50 | * bile acid metabolic process (GO:0008206) | 4.71737950 |
51 | phenylpropanoid metabolic process (GO:0009698) | 4.70935418 |
52 | alpha-amino acid catabolic process (GO:1901606) | 4.62427415 |
53 | glucocorticoid biosynthetic process (GO:0006704) | 4.61108926 |
54 | low-density lipoprotein particle remodeling (GO:0034374) | 4.58786421 |
55 | cholesterol efflux (GO:0033344) | 4.56817941 |
56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.52703882 |
57 | regulation of plasminogen activation (GO:0010755) | 4.48972287 |
58 | homocysteine metabolic process (GO:0050667) | 4.43276632 |
59 | lysine catabolic process (GO:0006554) | 4.37351152 |
60 | lysine metabolic process (GO:0006553) | 4.37351152 |
61 | glycine metabolic process (GO:0006544) | 4.36846220 |
62 | plasma lipoprotein particle assembly (GO:0034377) | 4.35602620 |
63 | C21-steroid hormone biosynthetic process (GO:0006700) | 4.34570678 |
64 | ketone body metabolic process (GO:1902224) | 4.33788578 |
65 | bile acid and bile salt transport (GO:0015721) | 4.33117261 |
66 | regulation of protein activation cascade (GO:2000257) | 4.30948813 |
67 | protein activation cascade (GO:0072376) | 4.30885251 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 4.30455821 |
69 | cellular glucuronidation (GO:0052695) | 4.27656430 |
70 | ethanol metabolic process (GO:0006067) | 4.26414384 |
71 | cellular amino acid catabolic process (GO:0009063) | 4.24830514 |
72 | glutamate metabolic process (GO:0006536) | 4.24471503 |
73 | negative regulation of lipase activity (GO:0060192) | 4.22318375 |
74 | drug metabolic process (GO:0017144) | 4.20854992 |
75 | response to follicle-stimulating hormone (GO:0032354) | 4.20450463 |
76 | negative regulation of hemostasis (GO:1900047) | 4.18807285 |
77 | negative regulation of blood coagulation (GO:0030195) | 4.18807285 |
78 | complement activation, alternative pathway (GO:0006957) | 4.17378188 |
79 | glucocorticoid metabolic process (GO:0008211) | 4.16017133 |
80 | negative regulation of protein activation cascade (GO:2000258) | 4.14390928 |
81 | S-adenosylmethionine metabolic process (GO:0046500) | 4.11966886 |
82 | C21-steroid hormone metabolic process (GO:0008207) | 4.11081277 |
83 | benzene-containing compound metabolic process (GO:0042537) | 4.08666708 |
84 | flavonoid metabolic process (GO:0009812) | 4.06864128 |
85 | positive regulation of lipid catabolic process (GO:0050996) | 4.06640418 |
86 | serine family amino acid metabolic process (GO:0009069) | 4.06346892 |
87 | androgen metabolic process (GO:0008209) | 4.04863108 |
88 | short-chain fatty acid metabolic process (GO:0046459) | 4.04323087 |
89 | indolalkylamine metabolic process (GO:0006586) | 4.00716847 |
90 | arginine metabolic process (GO:0006525) | 4.00641241 |
91 | alkaloid metabolic process (GO:0009820) | 3.99564488 |
92 | serine family amino acid biosynthetic process (GO:0009070) | 3.98227267 |
93 | aldehyde catabolic process (GO:0046185) | 3.97630331 |
94 | regulation of humoral immune response (GO:0002920) | 3.96264156 |
95 | complement activation, classical pathway (GO:0006958) | 3.96012046 |
96 | acute-phase response (GO:0006953) | 3.93826725 |
97 | plasma lipoprotein particle organization (GO:0071827) | 3.93737172 |
98 | cellular biogenic amine catabolic process (GO:0042402) | 3.93228201 |
99 | amine catabolic process (GO:0009310) | 3.93228201 |
100 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.92307901 |
101 | protein-lipid complex assembly (GO:0065005) | 3.91513766 |
102 | cellular modified amino acid catabolic process (GO:0042219) | 3.90963209 |
103 | complement activation (GO:0006956) | 3.90761496 |
104 | coenzyme catabolic process (GO:0009109) | 3.90441931 |
105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89780073 |
106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89780073 |
107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.89531903 |
108 | fibrinolysis (GO:0042730) | 3.89524912 |
109 | response to phenylpropanoid (GO:0080184) | 3.87334206 |
110 | cholesterol homeostasis (GO:0042632) | 3.86182158 |
111 | regulation of complement activation (GO:0030449) | 3.84913966 |
112 | phospholipid homeostasis (GO:0055091) | 3.84676962 |
113 | estrogen biosynthetic process (GO:0006703) | 3.83532838 |
114 | negative regulation of coagulation (GO:0050819) | 3.80791295 |
115 | blood coagulation, intrinsic pathway (GO:0007597) | 3.80727106 |
116 | negative regulation of wound healing (GO:0061045) | 3.80087541 |
117 | sterol homeostasis (GO:0055092) | 3.79734535 |
118 | uronic acid metabolic process (GO:0006063) | 3.78450619 |
119 | glucuronate metabolic process (GO:0019585) | 3.78450619 |
120 | hormone catabolic process (GO:0042447) | 3.77977518 |
121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.77430543 |
122 | * organic acid catabolic process (GO:0016054) | 3.75165674 |
123 | * carboxylic acid catabolic process (GO:0046395) | 3.75165674 |
124 | ethanol oxidation (GO:0006069) | 3.73871327 |
125 | * xenobiotic metabolic process (GO:0006805) | 3.71624986 |
126 | protein-lipid complex subunit organization (GO:0071825) | 3.70838189 |
127 | exogenous drug catabolic process (GO:0042738) | 3.63999657 |
128 | carnitine metabolic process (GO:0009437) | 3.63407962 |
129 | cofactor catabolic process (GO:0051187) | 3.62707115 |
130 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60456941 |
131 | lipoprotein metabolic process (GO:0042157) | 3.59210271 |
132 | linoleic acid metabolic process (GO:0043651) | 3.54700052 |
133 | sterol transport (GO:0015918) | 3.54342101 |
134 | cholesterol transport (GO:0030301) | 3.54342101 |
135 | heme transport (GO:0015886) | 3.51010857 |
136 | positive regulation of blood coagulation (GO:0030194) | 3.50052437 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.51742497 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.17783502 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.70679618 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.58675179 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19412144 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16998992 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.10846466 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.98139376 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.88370080 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06020454 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8298269 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96879115 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92930195 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60108169 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58847192 |
16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56352764 |
17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55727304 |
18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37466936 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30681684 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23485255 |
21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21785625 |
22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17863028 |
23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16224313 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15939143 |
25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12657373 |
26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09181753 |
27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05618855 |
28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04443931 |
29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04317116 |
30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01467762 |
31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01184790 |
32 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00645964 |
33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00597840 |
34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00230815 |
35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00211953 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99447426 |
37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99035385 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95772116 |
39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95277180 |
40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93328341 |
41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92301871 |
42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.92056786 |
43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91166801 |
44 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88368063 |
45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85210585 |
46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84432249 |
47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82897422 |
48 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82875551 |
49 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82863285 |
50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82202934 |
51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82024603 |
52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80957288 |
53 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.79625188 |
54 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79155573 |
55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78836029 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77006790 |
57 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76077952 |
58 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.75938195 |
59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.75618293 |
60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75389633 |
61 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73993282 |
62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73679203 |
63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.73353213 |
64 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.71619821 |
65 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.71199044 |
66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71084806 |
67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70816744 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 0.70809149 |
69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69972012 |
70 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69895891 |
71 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69895891 |
72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69607755 |
73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69574959 |
74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69354795 |
75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68809524 |
76 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68738440 |
77 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.68645705 |
78 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.67344477 |
79 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67310107 |
80 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.67292342 |
81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67271243 |
82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67039457 |
83 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.67010828 |
84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.66421538 |
85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66081876 |
86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66005672 |
87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.65795896 |
88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.65227062 |
89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65134017 |
90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.64391233 |
91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.64187020 |
92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64105706 |
93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.63987894 |
94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63075930 |
95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.62654320 |
96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.62654320 |
97 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.62300731 |
98 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.62256656 |
99 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.61705255 |
100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61482694 |
101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60501564 |
102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60501564 |
103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59798984 |
104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59133325 |
105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58305791 |
106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58232479 |
107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57307580 |
108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56777508 |
109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.55996662 |
110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51214836 |
111 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51122490 |
112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50744773 |
113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50546740 |
114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48840004 |
115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47763769 |
116 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47089554 |
117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47040199 |
118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46574841 |
119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46469834 |
120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.46291603 |
121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45975785 |
122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.45268078 |
123 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.45134502 |
124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44673654 |
125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43857012 |
126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42860602 |
127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42395343 |
128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41865121 |
129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.41252590 |
130 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.41124422 |
131 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.40691551 |
132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39875938 |
133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39341855 |
134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36956197 |
135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.36873117 |
136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36152889 |
137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35970290 |
138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.35482354 |
139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35342212 |
140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34864335 |
141 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.34507675 |
142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.34476541 |
143 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33933943 |
144 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.33918059 |
145 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.33121224 |
146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.33107939 |
147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.32835921 |
148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.32799956 |
149 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.32780215 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.50020397 |
2 | MP0005360_urolithiasis | 7.41014207 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.13237088 |
4 | MP0005365_abnormal_bile_salt | 6.02684910 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.62506671 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.21063202 |
7 | MP0010329_abnormal_lipoprotein_level | 3.71327487 |
8 | MP0009840_abnormal_foam_cell | 3.67285848 |
9 | MP0003252_abnormal_bile_duct | 3.59496236 |
10 | MP0005083_abnormal_biliary_tract | 3.23442847 |
11 | MP0003195_calcinosis | 3.00704501 |
12 | MP0005332_abnormal_amino_acid | 2.78018975 |
13 | MP0001666_abnormal_nutrient_absorption | 2.44839632 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.29871870 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.20088155 |
16 | MP0000609_abnormal_liver_physiology | 2.15561689 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.14513999 |
18 | MP0005451_abnormal_body_composition | 1.96983415 |
19 | MP0002909_abnormal_adrenal_gland | 1.91430357 |
20 | MP0002138_abnormal_hepatobiliary_system | 1.86534837 |
21 | MP0005319_abnormal_enzyme/_coenzyme | 1.77750889 |
22 | MP0003868_abnormal_feces_composition | 1.69966752 |
23 | MP0009697_abnormal_copulation | 1.67030025 |
24 | MP0001764_abnormal_homeostasis | 1.61700912 |
25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59938426 |
26 | MP0003122_maternal_imprinting | 1.41935561 |
27 | MP0003941_abnormal_skin_development | 1.40225473 |
28 | MP0000604_amyloidosis | 1.29884398 |
29 | MP0003011_delayed_dark_adaptation | 1.29496969 |
30 | MP0003656_abnormal_erythrocyte_physiolo | 1.23267262 |
31 | MP0003186_abnormal_redox_activity | 1.21928791 |
32 | MP0009643_abnormal_urine_homeostasis | 1.21413136 |
33 | MP0000598_abnormal_liver_morphology | 1.14862342 |
34 | MP0003705_abnormal_hypodermis_morpholog | 1.10865736 |
35 | MP0009764_decreased_sensitivity_to | 1.04255633 |
36 | MP0009763_increased_sensitivity_to | 1.01986576 |
37 | MP0005647_abnormal_sex_gland | 0.98901021 |
38 | MP0002254_reproductive_system_inflammat | 0.97066990 |
39 | MP0010368_abnormal_lymphatic_system | 0.93812228 |
40 | MP0001915_intracranial_hemorrhage | 0.90720469 |
41 | MP0009642_abnormal_blood_homeostasis | 0.87879350 |
42 | MP0005636_abnormal_mineral_homeostasis | 0.85552840 |
43 | MP0006036_abnormal_mitochondrial_physio | 0.83163799 |
44 | MP0008469_abnormal_protein_level | 0.82796258 |
45 | MP0005408_hypopigmentation | 0.82685193 |
46 | MP0002078_abnormal_glucose_homeostasis | 0.82664642 |
47 | MP0008995_early_reproductive_senescence | 0.82379266 |
48 | MP0009765_abnormal_xenobiotic_induced | 0.81059285 |
49 | MP0003329_amyloid_beta_deposits | 0.78630452 |
50 | MP0005376_homeostasis/metabolism_phenot | 0.78011655 |
51 | MP0002876_abnormal_thyroid_physiology | 0.76984744 |
52 | MP0002132_abnormal_respiratory_system | 0.76395765 |
53 | MP0003690_abnormal_glial_cell | 0.75979806 |
54 | MP0001661_extended_life_span | 0.75891337 |
55 | MP0002971_abnormal_brown_adipose | 0.75349465 |
56 | MP0009780_abnormal_chondrocyte_physiolo | 0.73571486 |
57 | MP0009053_abnormal_anal_canal | 0.72015237 |
58 | MP0005334_abnormal_fat_pad | 0.71666691 |
59 | MP0005670_abnormal_white_adipose | 0.71621782 |
60 | MP0000639_abnormal_adrenal_gland | 0.66700359 |
61 | MP0004130_abnormal_muscle_cell | 0.65864812 |
62 | MP0005084_abnormal_gallbladder_morpholo | 0.65286857 |
63 | MP0001756_abnormal_urination | 0.63145346 |
64 | MP0005535_abnormal_body_temperature | 0.62934930 |
65 | MP0005448_abnormal_energy_balance | 0.62694991 |
66 | MP0005464_abnormal_platelet_physiology | 0.61916183 |
67 | MP0005266_abnormal_metabolism | 0.60740147 |
68 | MP0002938_white_spotting | 0.58468620 |
69 | MP0002822_catalepsy | 0.57934409 |
70 | MP0008874_decreased_physiological_sensi | 0.57277189 |
71 | MP0003879_abnormal_hair_cell | 0.54555650 |
72 | MP0005220_abnormal_exocrine_pancreas | 0.54058347 |
73 | MP0002282_abnormal_trachea_morphology | 0.53919097 |
74 | MP0002837_dystrophic_cardiac_calcinosis | 0.53365226 |
75 | MP0006035_abnormal_mitochondrial_morpho | 0.53359348 |
76 | MP0003638_abnormal_response/metabolism_ | 0.52693564 |
77 | MP0005395_other_phenotype | 0.50696704 |
78 | MP0008872_abnormal_physiological_respon | 0.48503459 |
79 | MP0005248_abnormal_Harderian_gland | 0.47511023 |
80 | MP0008873_increased_physiological_sensi | 0.47218277 |
81 | MP0002136_abnormal_kidney_physiology | 0.46622300 |
82 | MP0004782_abnormal_surfactant_physiolog | 0.45938641 |
83 | MP0003075_altered_response_to | 0.45547271 |
84 | MP0001765_abnormal_ion_homeostasis | 0.45234159 |
85 | MP0003953_abnormal_hormone_level | 0.44424186 |
86 | MP0003436_decreased_susceptibility_to | 0.43317669 |
87 | MP0004883_abnormal_blood_vessel | 0.42576826 |
88 | MP0003718_maternal_effect | 0.42257976 |
89 | MP0000566_synostosis | 0.42073690 |
90 | MP0004142_abnormal_muscle_tone | 0.41134488 |
91 | MP0000249_abnormal_blood_vessel | 0.40785377 |
92 | MP0006082_CNS_inflammation | 0.39506682 |
93 | MP0005379_endocrine/exocrine_gland_phen | 0.39488844 |
94 | MP0003959_abnormal_lean_body | 0.39479533 |
95 | MP0005551_abnormal_eye_electrophysiolog | 0.38465445 |
96 | MP0009672_abnormal_birth_weight | 0.38431882 |
97 | MP0005167_abnormal_blood-brain_barrier | 0.38105167 |
98 | MP0003315_abnormal_perineum_morphology | 0.37572429 |
99 | MP0001243_abnormal_dermal_layer | 0.37122483 |
100 | MP0002168_other_aberrant_phenotype | 0.36802198 |
101 | MP0005666_abnormal_adipose_tissue | 0.35332825 |
102 | MP0009115_abnormal_fat_cell | 0.35211052 |
103 | MP0001853_heart_inflammation | 0.33792861 |
104 | MP0002928_abnormal_bile_duct | 0.32662291 |
105 | MP0003724_increased_susceptibility_to | 0.32023788 |
106 | MP0001324_abnormal_eye_pigmentation | 0.31873872 |
107 | MP0000230_abnormal_systemic_arterial | 0.31828424 |
108 | MP0002090_abnormal_vision | 0.30857123 |
109 | MP0002970_abnormal_white_adipose | 0.30852659 |
110 | MP0001984_abnormal_olfaction | 0.30643285 |
111 | MP0003950_abnormal_plasma_membrane | 0.30603658 |
112 | MP0005187_abnormal_penis_morphology | 0.29640738 |
113 | MP0000647_abnormal_sebaceous_gland | 0.29595489 |
114 | MP0003632_abnormal_nervous_system | 0.29209798 |
115 | MP0005164_abnormal_response_to | 0.27832007 |
116 | MP0003121_genomic_imprinting | 0.26769537 |
117 | MP0001845_abnormal_inflammatory_respons | 0.26537230 |
118 | MP0003183_abnormal_peptide_metabolism | 0.26404224 |
119 | MP0002089_abnormal_postnatal_growth/wei | 0.26147805 |
120 | MP0002249_abnormal_larynx_morphology | 0.24562370 |
121 | MP0005410_abnormal_fertilization | 0.24561477 |
122 | MP0003633_abnormal_nervous_system | 0.23597586 |
123 | MP0001881_abnormal_mammary_gland | 0.23548919 |
124 | MP0005166_decreased_susceptibility_to | 0.22856014 |
125 | MP0005595_abnormal_vascular_smooth | 0.21215860 |
126 | MP0002269_muscular_atrophy | 0.20789547 |
127 | MP0003300_gastrointestinal_ulcer | 0.20379054 |
128 | MP0005058_abnormal_lysosome_morphology | 0.18673653 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.72897971 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.58765241 |
3 | Hypobetalipoproteinemia (HP:0003563) | 6.86527259 |
4 | Intrahepatic cholestasis (HP:0001406) | 6.75299479 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64617119 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.56281847 |
7 | Xanthomatosis (HP:0000991) | 6.32902763 |
8 | Hyperlipoproteinemia (HP:0010980) | 6.14229296 |
9 | Hypolipoproteinemia (HP:0010981) | 5.10385477 |
10 | Joint hemorrhage (HP:0005261) | 4.98695526 |
11 | Hyperammonemia (HP:0001987) | 4.71147586 |
12 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.69073076 |
13 | Hypoalphalipoproteinemia (HP:0003233) | 4.46223281 |
14 | Abnormality of methionine metabolism (HP:0010901) | 4.43623361 |
15 | Hyperglycinemia (HP:0002154) | 4.42869720 |
16 | Ketosis (HP:0001946) | 4.41708862 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37801716 |
18 | Epidermoid cyst (HP:0200040) | 4.25714424 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24840575 |
20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21249330 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12429992 |
22 | Hyperglycinuria (HP:0003108) | 4.11845064 |
23 | Abnormality of glycine metabolism (HP:0010895) | 4.07224480 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07224480 |
25 | Hypoglycemic coma (HP:0001325) | 4.03482882 |
26 | Hypercholesterolemia (HP:0003124) | 3.93641718 |
27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.84618347 |
28 | Renal salt wasting (HP:0000127) | 3.73858949 |
29 | Fat malabsorption (HP:0002630) | 3.70469883 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63401688 |
31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53292801 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47927447 |
33 | Hyperbilirubinemia (HP:0002904) | 3.45962373 |
34 | Complement deficiency (HP:0004431) | 3.43492983 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41266699 |
36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32841220 |
37 | Delayed CNS myelination (HP:0002188) | 3.32742984 |
38 | Ketoacidosis (HP:0001993) | 3.24452189 |
39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09435225 |
40 | Sex reversal (HP:0012245) | 3.08047527 |
41 | Abnormal sex determination (HP:0012244) | 3.08047527 |
42 | Abnormality of serum amino acid levels (HP:0003112) | 3.06499456 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.93142513 |
44 | Metabolic acidosis (HP:0001942) | 2.90952740 |
45 | Spontaneous abortion (HP:0005268) | 2.89805253 |
46 | Vascular calcification (HP:0004934) | 2.88255808 |
47 | Myocardial infarction (HP:0001658) | 2.78811465 |
48 | Dicarboxylic aciduria (HP:0003215) | 2.76768974 |
49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76768974 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.71843664 |
51 | Steatorrhea (HP:0002570) | 2.67366931 |
52 | Lethargy (HP:0001254) | 2.66457997 |
53 | Glomerulonephritis (HP:0000099) | 2.65486624 |
54 | Skin nodule (HP:0200036) | 2.62723888 |
55 | Osteomalacia (HP:0002749) | 2.60553055 |
56 | Hypochromic microcytic anemia (HP:0004840) | 2.60151713 |
57 | Cardiovascular calcification (HP:0011915) | 2.56825584 |
58 | Hypoglycemic seizures (HP:0002173) | 2.55198389 |
59 | Malnutrition (HP:0004395) | 2.52773324 |
60 | Spastic diplegia (HP:0001264) | 2.52094899 |
61 | Arthropathy (HP:0003040) | 2.50922958 |
62 | Abnormality of complement system (HP:0005339) | 2.49058140 |
63 | Reduced antithrombin III activity (HP:0001976) | 2.45959559 |
64 | Acanthocytosis (HP:0001927) | 2.45355715 |
65 | Cerebral edema (HP:0002181) | 2.43843570 |
66 | Mitral stenosis (HP:0001718) | 2.42657825 |
67 | Menorrhagia (HP:0000132) | 2.39852823 |
68 | Irritability (HP:0000737) | 2.39121567 |
69 | Abnormal gallbladder morphology (HP:0012437) | 2.38928866 |
70 | Amyloidosis (HP:0011034) | 2.36723519 |
71 | Gout (HP:0001997) | 2.32286667 |
72 | Cholelithiasis (HP:0001081) | 2.31848187 |
73 | Esophageal varix (HP:0002040) | 2.27064443 |
74 | Abnormality of vitamin metabolism (HP:0100508) | 2.26439362 |
75 | Fair hair (HP:0002286) | 2.21140591 |
76 | Late onset (HP:0003584) | 2.19280272 |
77 | Gingival bleeding (HP:0000225) | 2.18868909 |
78 | Purpura (HP:0000979) | 2.16186803 |
79 | Generalized aminoaciduria (HP:0002909) | 2.15444233 |
80 | Abnormal gallbladder physiology (HP:0012438) | 2.15389627 |
81 | Cholecystitis (HP:0001082) | 2.15389627 |
82 | Hyperphosphaturia (HP:0003109) | 2.14878350 |
83 | Neonatal onset (HP:0003623) | 2.14664362 |
84 | Vomiting (HP:0002013) | 2.14606237 |
85 | Azoospermia (HP:0000027) | 2.14219008 |
86 | Hyperaldosteronism (HP:0000859) | 2.13140022 |
87 | Pancreatitis (HP:0001733) | 2.11656229 |
88 | Brushfield spots (HP:0001088) | 2.10924955 |
89 | Poikilocytosis (HP:0004447) | 2.08569468 |
90 | Thrombophlebitis (HP:0004418) | 2.08172285 |
91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07265077 |
92 | Cerebral palsy (HP:0100021) | 2.05515207 |
93 | Enlarged kidneys (HP:0000105) | 2.04820534 |
94 | Abnormality of proline metabolism (HP:0010907) | 2.03359652 |
95 | Hydroxyprolinuria (HP:0003080) | 2.03359652 |
96 | Hemorrhage of the eye (HP:0011885) | 2.03250978 |
97 | Opisthotonus (HP:0002179) | 2.00776948 |
98 | Alkalosis (HP:0001948) | 1.99048583 |
99 | Potter facies (HP:0002009) | 1.99007019 |
100 | Facial shape deformation (HP:0011334) | 1.99007019 |
101 | Hypophosphatemic rickets (HP:0004912) | 1.91004637 |
102 | Rickets (HP:0002748) | 1.90443908 |
103 | Sensorimotor neuropathy (HP:0007141) | 1.89119436 |
104 | Bifid scrotum (HP:0000048) | 1.88797612 |
105 | Reticulocytosis (HP:0001923) | 1.87907499 |
106 | Nephritis (HP:0000123) | 1.87346408 |
107 | Renal cortical cysts (HP:0000803) | 1.86747284 |
108 | Systemic lupus erythematosus (HP:0002725) | 1.85711515 |
109 | Abnormality of the gallbladder (HP:0005264) | 1.85113916 |
110 | Abnormal cartilage morphology (HP:0002763) | 1.84399022 |
111 | Abnormality of iron homeostasis (HP:0011031) | 1.84343276 |
112 | Status epilepticus (HP:0002133) | 1.83999676 |
113 | Bile duct proliferation (HP:0001408) | 1.82520478 |
114 | Abnormal biliary tract physiology (HP:0012439) | 1.82520478 |
115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81302064 |
116 | Joint swelling (HP:0001386) | 1.80538096 |
117 | Proximal tubulopathy (HP:0000114) | 1.80137857 |
118 | Glycosuria (HP:0003076) | 1.79935279 |
119 | Abnormality of urine glucose concentration (HP:0011016) | 1.79935279 |
120 | Increased serum pyruvate (HP:0003542) | 1.78821876 |
121 | Pulmonary embolism (HP:0002204) | 1.78493738 |
122 | Abnormal urine phosphate concentration (HP:0012599) | 1.72594191 |
123 | Mucopolysacchariduria (HP:0008155) | 1.69745800 |
124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69745800 |
125 | Clitoromegaly (HP:0000057) | 1.69679336 |
126 | Decreased circulating renin level (HP:0003351) | 1.64899556 |
127 | Elevated alkaline phosphatase (HP:0003155) | 1.63387793 |
128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57427928 |
129 | Neonatal hypoglycemia (HP:0001998) | 1.56800614 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.69634287 |
2 | SIK1 | 5.19954119 |
3 | AKT3 | 4.50522891 |
4 | FGFR4 | 4.30386798 |
5 | ERN1 | 3.62680583 |
6 | PKN2 | 3.43821398 |
7 | INSRR | 2.86245249 |
8 | TAOK3 | 2.67092660 |
9 | FLT3 | 2.50053381 |
10 | MAP2K4 | 2.36928274 |
11 | ACVR1B | 2.36367822 |
12 | PIK3CA | 2.34057076 |
13 | WNK4 | 2.25177626 |
14 | PIK3CG | 2.21016133 |
15 | TRIB3 | 2.08632120 |
16 | MST1R | 2.06498381 |
17 | DAPK2 | 1.99460177 |
18 | WNK3 | 1.84532903 |
19 | TYK2 | 1.73816907 |
20 | NTRK3 | 1.63942957 |
21 | KDR | 1.60225298 |
22 | MAP3K12 | 1.51253908 |
23 | PTK6 | 1.50777388 |
24 | ABL2 | 1.43318913 |
25 | FGFR2 | 1.39189312 |
26 | MAP4K2 | 1.37267095 |
27 | CAMKK2 | 1.36249155 |
28 | ADRBK2 | 1.33430753 |
29 | BMPR1B | 1.32847682 |
30 | CDK7 | 1.32501109 |
31 | LATS1 | 1.28747888 |
32 | PINK1 | 1.26096795 |
33 | FRK | 1.23765124 |
34 | MAPK11 | 1.18522421 |
35 | CASK | 1.18331219 |
36 | MAP2K3 | 1.16840710 |
37 | ERBB4 | 1.15386571 |
38 | PRKAA2 | 1.11435989 |
39 | JAK2 | 1.09257366 |
40 | GRK5 | 1.08679412 |
41 | MAP3K2 | 1.06678407 |
42 | MAPKAPK3 | 1.06047168 |
43 | FER | 1.04379101 |
44 | GRK6 | 1.03560197 |
45 | MAPK4 | 1.03465516 |
46 | NEK9 | 1.00153178 |
47 | MAP3K7 | 0.99488278 |
48 | TBK1 | 0.97983675 |
49 | SGK1 | 0.95687696 |
50 | EPHA4 | 0.95476330 |
51 | PRKCZ | 0.92955955 |
52 | CSK | 0.92804786 |
53 | JAK1 | 0.92170947 |
54 | MAP3K10 | 0.91224285 |
55 | MAP3K14 | 0.90028188 |
56 | TIE1 | 0.89086929 |
57 | MAP3K3 | 0.87155556 |
58 | MAP3K11 | 0.87093388 |
59 | MAPK12 | 0.85554432 |
60 | CAMK1D | 0.84785489 |
61 | MYLK | 0.83800974 |
62 | MET | 0.83669251 |
63 | NLK | 0.83033002 |
64 | EPHB1 | 0.82750743 |
65 | CDK6 | 0.81527941 |
66 | STK39 | 0.80909248 |
67 | CSNK1D | 0.80858815 |
68 | DYRK1B | 0.80777489 |
69 | PRKACG | 0.79878237 |
70 | PRKG1 | 0.78316264 |
71 | TGFBR2 | 0.74203061 |
72 | MAP2K6 | 0.69288447 |
73 | AKT2 | 0.67936646 |
74 | RIPK1 | 0.66795109 |
75 | GSK3A | 0.65640564 |
76 | EIF2AK3 | 0.61251409 |
77 | CSF1R | 0.61033496 |
78 | CSNK1E | 0.60788782 |
79 | SGK3 | 0.59932943 |
80 | RET | 0.59400936 |
81 | PRKAA1 | 0.59387899 |
82 | CSNK1A1 | 0.58378257 |
83 | PTK2 | 0.57480004 |
84 | RPS6KA3 | 0.57214875 |
85 | PRKCQ | 0.56435791 |
86 | MAPK7 | 0.55382561 |
87 | PDPK1 | 0.54973059 |
88 | TAOK2 | 0.54821475 |
89 | PRKCB | 0.54768068 |
90 | STK38L | 0.54550694 |
91 | CSNK1G1 | 0.53738538 |
92 | STK16 | 0.53259768 |
93 | MAP3K4 | 0.53145815 |
94 | DYRK2 | 0.52866441 |
95 | MAPK3 | 0.51518097 |
96 | PRKCE | 0.51097365 |
97 | ERBB2 | 0.50704088 |
98 | BCR | 0.48759668 |
99 | EPHA3 | 0.48723494 |
100 | TYRO3 | 0.48676385 |
101 | TLK1 | 0.47352836 |
102 | PDK2 | 0.46900740 |
103 | GRK1 | 0.46594232 |
104 | MAP3K13 | 0.46222030 |
105 | PRKCG | 0.45840596 |
106 | RPS6KB1 | 0.45238766 |
107 | PDK1 | 0.44836224 |
108 | IGF1R | 0.44620650 |
109 | BRSK2 | 0.43982132 |
110 | FGFR3 | 0.43432809 |
111 | EIF2AK1 | 0.43296027 |
112 | CAMK2G | 0.42747116 |
113 | SGK2 | 0.42288807 |
114 | IKBKE | 0.42026125 |
115 | MUSK | 0.40674769 |
116 | ZAK | 0.40142590 |
117 | PRKACB | 0.39238996 |
118 | MAP3K5 | 0.38998340 |
119 | MAP2K1 | 0.38821269 |
120 | CDK4 | 0.37904437 |
121 | MAP3K6 | 0.37747035 |
122 | CSNK1G2 | 0.37542863 |
123 | PDK4 | 0.35745885 |
124 | PDK3 | 0.35745885 |
125 | ICK | 0.34456146 |
126 | SGK223 | 0.34010123 |
127 | SGK494 | 0.34010123 |
128 | CSNK1G3 | 0.33607561 |
129 | CAMK4 | 0.33162248 |
130 | CAMKK1 | 0.32399826 |
131 | CAMK1G | 0.31346534 |
132 | PBK | 0.30110108 |
133 | MTOR | 0.29132736 |
134 | PRKCA | 0.27404206 |
135 | MAP3K1 | 0.25944393 |
136 | MAPK15 | 0.25760740 |
137 | FGFR1 | 0.25077566 |
138 | CSNK1A1L | 0.23984005 |
139 | LATS2 | 0.23254469 |
140 | BLK | 0.23037950 |
141 | IRAK3 | 0.20561669 |
142 | MAP2K2 | 0.20366521 |
143 | EGFR | 0.19941456 |
144 | PRKACA | 0.19823548 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.98555329 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.69733128 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64597934 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25772045 |
5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.17090327 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98506728 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64585646 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60271700 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51927040 |
10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46935842 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46721156 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42669545 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42541724 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31898111 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25944657 |
16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.05740022 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03709052 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.00060003 |
19 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98638376 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94361179 |
21 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94222297 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92444225 |
23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.92286055 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89473548 |
25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88906128 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80133059 |
27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78042464 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73874507 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73721298 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67754303 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67391201 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54096731 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53498185 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50991673 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47351046 |
36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46742370 |
37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39430842 |
38 | * Bile secretion_Homo sapiens_hsa04976 | 1.39321479 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36541025 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32625350 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29000260 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24165004 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.20199354 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17529689 |
45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17314702 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17175340 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13908232 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10756163 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07768116 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06874791 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03094167 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92316456 |
53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87303655 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86904074 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85967393 |
56 | Lysine degradation_Homo sapiens_hsa00310 | 0.84403038 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84264071 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79072699 |
59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73988171 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73943337 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69956603 |
62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57543045 |
63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57528894 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56783741 |
65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52700540 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50171017 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45090627 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35095292 |
69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28891634 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28830645 |
71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28264748 |
72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26254285 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23795733 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22687941 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21699862 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20571373 |
77 | Mineral absorption_Homo sapiens_hsa04978 | 0.13487829 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13062788 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08982771 |
80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.02970343 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01819233 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01708970 |
83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00960675 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2591679 |
85 | Pertussis_Homo sapiens_hsa05133 | -0.2582258 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2554276 |
87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2475731 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2437615 |
89 | Hepatitis C_Homo sapiens_hsa05160 | -0.2401494 |
90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2347520 |
91 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2230964 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2115718 |
93 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2081719 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1936204 |
95 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1839908 |
96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1838526 |
97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1836134 |
98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1765879 |
99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1557193 |
100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1547974 |
101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1476916 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1445203 |
103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1227310 |
104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1085792 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1030365 |
106 | Prion diseases_Homo sapiens_hsa05020 | -0.0975875 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0968883 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0353127 |
109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0268041 |
110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0164288 |